Product Information
DULOXETINE HCL DR 30 MG CAP is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1058 per EA under NDC 31722016930. Its NADAC has been published 220 times since Jun 8, 2022.
FDA first approved this application on Aug 3, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722016930
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DULOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204343FDA Approved
8/3/2016
TE Code
AB
On Market Since
12/30/2020
Pharmacological Classes
Price Statistics
The NADAC for DULOXETINE HCL DR 30 MG CAP has been published 220 times since Jun 8, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1058 per EA |
|---|---|
| All-time high | $0.1087 (Dec 13, 2023) |
| All-time low | $0.0696 (May 22, 2024) |
| 52-week high | $0.1058 |
| 52-week low | $0.0781 |
| Median price | $0.0937 |
| Average price | $0.0894 |
| Largest weekly change | -19.4% (Apr 17, 2024) |
| Weeks tracked | 220 |
| Tracking since | Jun 8, 2022 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DULOXETINE HCL DR 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 30 MG CAP, manufactured by Camber Pharmaceuticals Inc., is $0.1058 per EA (NDC 31722016930), effective Aug 19, 2026.
How has the price of DULOXETINE HCL DR 30 MG CAP changed over time?
Over the history we have for it, the NADAC for DULOXETINE HCL DR 30 MG CAP has held within roughly two percent of its current level. It has been tracked across 220 weekly CMS publications since Jun 8, 2022.
What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 30 MG CAP?
Since Jun 8, 2022, the NADAC for DULOXETINE HCL DR 30 MG CAP has ranged from a low of $0.0696 (May 22, 2024) to a high of $0.1087 (Dec 13, 2023), with a median of $0.0937 per EA.
Are there cheaper alternatives to DULOXETINE HCL DR 30 MG CAP?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DULOXETINE HCL DR 30 MG CAP, is $0.0782 per EA — about 26% below DULOXETINE HCL DR 30 MG CAP.
Who manufactures DULOXETINE HCL DR 30 MG CAP?
DULOXETINE HCL DR 30 MG CAP (NDC 31722016930) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.